Kelly Financial Services LLC Haleon PLC Transaction History

Kelly Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$8.01 - $8.64 $6,472 - $6,981	-808 Reduced 91.2%	78 $0
Q4 2023 Jul 17, 2024	BUY	$7.78 - $8.62 $15 - $17	2 Added 0.23%	886 $7.29 Million
Q3 2023 Jul 17, 2024	BUY	$7.85 - $8.94 $3,187 - $3,629	406 Added 84.94%	884 $7.36 Million
Q2 2023 Jul 17, 2024	BUY	$8.04 - $9.0 $3,232 - $3,618	402 Added 528.95%	478 $4 Million
Q1 2023 Jul 17, 2024	SELL	$7.57 - $8.37 $348 - $385	-46 Reduced 37.7%	76 $619,000
Q4 2022 Jul 17, 2024	SELL	$5.96 - $8.06 $1,197 - $1,620	-201 Reduced 62.23%	122 $976,000
Q3 2022 Jul 17, 2024	BUY	$5.63 - $7.5 $1,818 - $2,422	323 New	323 $1.97 Million

617

423M

165K

26.7K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $42.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.